In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of ...

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 ...

In July 2015, Abbott agreed to buy Tendyne for $225 million upfront and secured an option to acquire Cephea. Abbott CEO ...

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

Stryker said Monday it has closed its takeover of ZuriMED, adding a device for treating rotator cuff tears to its portfolio.

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, ...

The Millennium deal is the third takeover disclosed by Labcorp in eight days. The flurry of activity began on Oct. 15 when ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated ...